<DOC>
	<DOCNO>NCT00185042</DOCNO>
	<brief_summary>The purpose study learn CS-505 safe effective slowing possibly reverse buildup tissue , cell fatty deposit ( plaque ) blood vessel heart ( coronary artery atherosclerosis ) .</brief_summary>
	<brief_title>Efficacy Safety ACAT Inhibitor CS-505 ( Pactimibe ) Reducing Progression Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Standard : 1 . Male female subject , age 18 year great ; 2 . Diagnosed suspected coronary artery disease clinical indication coronary angiography . Angiographic : 1 . Evidence coronary heart disease 2 . Identification target native coronary artery plaque volume measurement . Standard : 1 . Breast feed lactate woman , woman pregnancy ( regardless outcome ) within past 12 month ; 2 . Previous heart organ transplantation ; 3 . Treatment follow agent within 4 week prior randomization : Immunosuppressive agent ( cyclosporine , azathioprine ) ; Rifampin ; Phenytoin , phenobarbital , valproic acid , anticonvulsant . 4 . Any following manifestation cardiac disease : Myocardial infarction unstable angina within 24 hour prior randomization clinically unstable ; Clinically significant heart disease ; Coronary artery bypass surgery within previous 3 month . 5 . Stroke ( CVA ) within previous 3 month ; 6 . Evidence severe symptomatic heart failure ( NYHA Class III IV ) know ejection fraction le 30 % ; 7 . Uncontrolled diabetes mellitus ; 8 . Uncontrolled hypertension ; 9 . Nephrotic syndrome , significant nephropathy , significant renal disease . Angiographic : 1 . Presence lesion great 50 % reduction lumen diameter ; 2 . Any lesion great 50 % occlusion leave main coronary artery ; 3 . A target vessel , include branch , undergone undergoing coronary artery bypass grafting ( CABG ) percutaneous coronary intervention ( PCI ) ; 4 . A target vessel bypass graft .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Atherosclerosis , intravascular ultrasound</keyword>
</DOC>